Synlogic, Inc.

83 employees

Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

rare disease

Synthetic Biotics

IBD

nephrology

Synthetic Biology

Health Care

Therapeutics

Rare Metabolic Diseases

gout

clinical development

Phase 3

synbio

HCU

Drug Development

PKU

homocystinuria

phenylketonuria

Synbio

Date founded

2014

Funding rounds raised

Total raised

$80M

from 10 investors over 10 rounds

Synlogic, Inc. raised $80M on June 12, 2019

Investors: Ginkgo Bioworks, Inc.

Synlogic, Inc. raised $42M on May 16, 2017

Investors: Atlas Venture, CLI Ventures, Perceptive Advisors and OrbiMed Advisors

Synlogic, Inc. raised $40M on February 17, 2016

Investors: Atlas Venture and OrbiMed Advisors

Synlogic, Inc. raised $5M on October 7, 2014

Investors: Bill & Melinda Gates Foundation and Atlas Venture

Synlogic, Inc. raised $29M on July 22, 2014

Investors: Atlas Venture